Maryland Prescription Drug Affordability Board

​Announcements

• The Prescription Drug Affordability Stakeholder Council Meeting will now take place on November 4, 2024. More information can be found here.
  
• The next meeting of the Prescription Drug Affordability Board will take place on November 25, 2024. More information can be found here​.
  

• NOTICE: COMAR 14.01.04 Cost Review Study Process,​Emergency Action- The Prescription Drug Affordability Board seeks emergency action on proposed amendments to .05 under COMAR 14.01.04 Cost Review Study Process.  The text of the proposed amendments is available here​. 

• The PDAB is soliciting comments informing the development of draft regulations. Please visit this page​ for more information. ​Written Comments are due November 8, 2024

• ​Written Comment Request: Posted 10/28/2024
  In accordance with COMAR 14.01.01.05B(4), the Prescription Drug Affordability Board requests public written comment for the cost review study process on:  
  Farxiga, Jardiance, Ozem​pic, and Trulicity.  ​
  
  Patient experience and clinician input regarding these drugs are of particular interest but all comments concerning these drug products are encouraged.  Written comments are due by the close of business, Friday, November 8, 2024. Please submit written comments to comments.pdab@maryland.gov​ with the subject line “(Drug Name) Comments.”

  
  

• NOTICE OF PROPOSED ACTION:
  COMAR 14.01.04 Cost Review Study Process
  The Maryland Prescription Drug Affordability Board proposes to amend Regulation .05 under COMAR 14.01.04 Cost Review Study Process. The text of the proposed amendments are available in the November 1, 2024 version of the Maryland register located here. 
  Please visit the regulations page​ for more information including how to submit comments. Comments are due December 2, 2024.
  
  
  
  

Join the Prescription Drug Affordability Board's Mailing List
Please ​ follow the instructions to register for the PDAB's Mailing List. This will allow you to keep up to date on the actions of the PDAB.​